UiPath Slips 3% Despite Citi Buy Initiation and $23 Target, Pegasystems and C3.ai Lag

UiPath Slips 3% Despite Citi Buy Initiation and $23 Target, Pegasystems and C3.ai Lag

David Moadel

Wed, September 9, 2026 at 8:45 PM GMT+3 5 min read

Quick Read

• UiPath sank 4% to $13.49 despite Citi's fresh Buy rating and $23 target, as a below-expectations Q3 revenue guide of $442.5M spooked investors.

• Peers Pegasystems and C3.ai dropped 3% and 1% respectively, as the market demands proven AI-era monetization over strategic pitches.

• UiPath's September 22 investor day and Fusion conference are the next catalysts, with bulls pointing to $1.4B cash and zero debt as the floor.

• Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and UiPath didn't make the cut. Enter your email to see the names that beat PATH. The report is free. Enter your email and see if any of your stocks made the cut.

Shares of UiPath (NYSE:PATH) are down 3% to $13.55 midday Wednesday, sliding even after Citi initiated coverage with a fresh Buy rating and a $23 price target. The move extends a rough stretch for the automation software vendor, which has struggled to hold gains around its most recent quarterly report.

The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is down 0.44% in the same session. Meanwhile, the iShares Expanded Tech-Software Sector ETF (CBOE:IGV) is down 0.3%. Today's price action in UiPath stock appears to be company-specific rather than a broad rotation out of enterprise software.

Citi Buy Call Meets a Guidance Hangover

Citi's Yitchuin Wong initiated coverage of UiPath stock with a Buy rating and a $23 price target, framing the post-earnings weakness as an attractive entry for long-term holders and pointing to UiPath's role as an orchestration layer for corporate AI deployment. It's an initiation of coverage rather than an upgrade, so the vote of confidence is arriving from a firm that hadn't previously carried the name.

Free Report, Just Released

Why Didn't PATH Make The Top 10 List?

24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.

And PATH didn't make the cut!

The report is free, and you can see why we think each stock is a top investment today.

Enter Your Email and See the Ten →

The selling that preceded today's move followed UiPath's third-quarter revenue guide of $442.5 million, issued earlier this month, which landed below Wall Street expectations. Management on the September 3 call posted revenue of $410 million, up 13% year over year, with annual recurring revenue (ARR) reaching $1.938 billion and non-GAAP operating margin expanding to 22%.

CEO Daniel Dines told analysts that customers are turning to UiPath "not just to automate individual tasks, but to orchestrate complex, long-running, and exception-heavy business processes." Retail sentiment has split between those treating the reaction as overdone at a profitable, debt-free company and those focused on decelerating ARR growth and stiffer competition in automation software.

UiPath ended its quarter with roughly 10,350 customers, and its largest cohort keeps expanding. Customers spending $1 million or more in ARR grew 21% to 387, and dollar-based net retention held at 109%. Those figures underpin Citi's argument that the underlying franchise looks stronger than the guide alone suggests.

Enterprise Automation Peers Also Under Pressure

Pegasystems (NASDAQ:PEGA) stock is down 2% to $34.99. The workflow vendor's second-quarter results in July showed total annual contract value (ACV) growth of just 7%, with CEO Alan Trefler citing customer purchasing delays tied to "unprecedented change in the software market" and highly variable token costs.

Also down is C3.ai (NYSE:AI) stock, which is off by 2% to $10.33. The enterprise AI vendor beat estimates last week with revenue of $52.38 million and bookings up 73% quarter over quarter, though its top line was still down sharply from $70.26 million a year ago as founder Thomas Siebel's turnaround plays out.

The sector's shift is visible across results. Pegasystems has pushed its Pega Infinity 26 release, saying it doesn't charge per token. C3.ai closed 22 agreements last quarter with counterparties including Ford Motor (NYSE:F), Johnson & Johnson (NYSE:JNF), and U.S. federal agencies.

The group's common thread is investor caution around AI-era monetization. Pegasystems has leaned into design-time AI with predictable pricing, C3.ai is rebuilding around its agentic platform, and UiPath is pitching model-agnostic orchestration. Today's action suggests the market wants demonstrated results before rewarding pitch decks.

What to Watch Next

UiPath's investor day on September 22, followed by its Fusion user conference from September 23 to 25 in Las Vegas, is the next scheduled catalyst that could reset the narrative around ARR quality and agent orchestration. Investors can watch for whether management uses those events to reframe the third-quarter guide.

The bull case rests on a profitable operator with $1.4 billion in cash and no debt, trading well below Citi's target. The bear case leans on slowing ARR growth, a crowded automation field, and the same customer hesitation that hit Pegasystems in July.

Readers weighing their exposure may want to keep an eye on whether today's Buy initiation attracts additional coverage before the investor day. Position sizing should reflect that UiPath stock has been volatile through the recent earnings cycle, and between now and Q3 FY2027 results, investor day framing plus any follow-on analyst notes could drive the short-term trade.

Got $1,000? Before You Buy PATH, Read This

If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And PATH wasn't one of them.

They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list -->>

Contact editorial@247wallst.com for any questions or corrections.